Related Experiment Videos
Intermediate clinical events, surrogate markers and survival
1Dana-Farber Cancer Institute, USA.
Lifetime Data Analysis
|January 1, 1995
Summary
This study introduces methods to compare survival times when intermediate events occur before death. These statistical approaches enhance survival analysis for therapies and strengthen existing comparison tests.
Area of Science:
- Biostatistics
- Survival Analysis
- Clinical Trials
Background:
- Comparing survival distributions is crucial in medical research.
- Standard methods may not fully account for intermediate events that affect patient outcomes.
- Intermediate events can be complex, including polychotomous types.
Purpose of the Study:
- To develop statistical methods for comparing survival times in the presence of intermediate events.
- To derive score tests for assessing the impact of intermediate events on survival.
- To enhance existing survival analysis techniques, including the log rank test.
Main Methods:
- Investigated one- and two-sample survival problems with intermediate events.
- Derived score tests to evaluate if intermediate events alter survival distributions.
- Utilized exact distribution calculations by conditioning on waiting time and event occurrence.
Main Results:
- Developed novel score tests for survival data with intermediate events.
- Demonstrated the applicability of these methods for non-randomized therapy evaluations.
- Provided a framework to strengthen the log rank test.
Conclusions:
- The proposed score tests offer a robust way to analyze survival data with intermediate events.
- These methods improve the evaluation of therapies and the comparison of survival distributions.
- The exact distribution of score tests provides a reliable statistical basis.